AS

Akash Suresh Puranik

Active Director Director DIN 06775891
DIN 06775891 First appointment Dec 2013 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Dec 2013
Shareholding value •••• Premium profile

About Akash Suresh Puranik

Data last updated:

Akash Suresh Puranik has 12 years in corporate governance. Holds Director and Managing Director roles. Currently with 5 companies, including Vpl Chemicals Private Limited and Copernicium Pharmaceuticals Private Limited. Formerly with 2 companies, such as Launchmydrug Technologies Private Limited and Blumen Biovitals Healthkare Private Limited. Engaged in General Business, Technology and more. The 4 current companies with reported revenue have a combined latest revenue of ₹499 Cr; the largest is Symbio Generrics India Private Limited at ₹435 Cr (FY 2025).

DIN 06775891
Primary Designation Director
First Appointment 23 Dec 2013
Oldest Company Age 26 yrs
Largest company Symbio Generrics India Private Limited · ₹435 Cr (FY 2025)
Combined revenue ₹499 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director30 Sep 20172011₹435 Cr (FY 2025)Active
Vpl Chemicals Private Limited U24100KA1999PTC025992
Director30 Jun 20221999₹57.32 Cr (FY 2025)Active
Director23 Dec 20132013₹6.15 Cr (FY 2024)Active
Sequent Penems Private Limited U24233KA2010PTC053548
Director25 Apr 20242010₹70.9 Lakh (FY 2025)Active
Director03 Nov 20172017–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Feb 20182017–Strike Off
Director24 Aug 20172017₹1.57 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vpl Chemicals Private Limited
Copernicium Pharmaceuticals Private Limited
Symbio Generrics India Private Limited
Symbio Natural Products Private Limited
Premium access

Shareholding and investment profile for Akash Suresh Puranik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akash Suresh Puranik

Akash Suresh Puranik has 12 years in corporate governance. Holds Director and Managing Director roles. Currently with 5 companies, including Vpl Chemicals Private Limited and Copernicium Pharmaceuticals Private Limited. Formerly with 2 companies, such as Launchmydrug Technologies Private Limited and Blumen Biovitals Healthkare Private Limited. Engaged in General Business, Technology and more. The 4 current companies with reported revenue have a combined latest revenue of ₹499 Cr; the largest is Symbio Generrics India Private Limited at ₹435 Cr (FY 2025).

Akash Suresh Puranik is associated with 5 companies as Director and Managing Director, including Symbio Generrics India Private Limited (₹435 Cr), Vpl Chemicals Private Limited (₹57.32 Cr), Copernicium Pharmaceuticals Private Limited (₹6.15 Cr).

Akash Suresh Puranik has expertise in General Business, Technology and other sectors.

Akash Suresh Puranik has 12 years in corporate governance.

By reported revenue, the largest current company of Akash Suresh Puranik is Symbio Generrics India Private Limited, with revenue of ₹435 Cr (FY 2025).

The 4 current companies of Akash Suresh Puranik that report revenue have a combined latest revenue of ₹499 Cr.

Akash Suresh Puranik currently holds positions at 5 companies: Symbio Generrics India Private Limited (₹435 Cr), Vpl Chemicals Private Limited (₹57.32 Cr), Copernicium Pharmaceuticals Private Limited (₹6.15 Cr), Sequent Penems Private Limited (₹70.9 Lakh), Symbio Natural Products Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available